Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

A novel tumor necrosis factor-alpha inhibitory protein, TIP-B1.

Berleth ES, Henn AD, Gurtoo HL, Wollman R, Alderfer JL, Mihich E, Ehrke MJ.

Int J Immunopharmacol. 2000 Dec;22(12):1137-42.

PMID:
11137621
2.

A novel TNF-inducible message with putative growth suppressor function.

Nadadur SS, Ehrke MJ, Gurtoo HL.

Biochim Biophys Acta. 1999 Dec 23;1489(2-3):433-9.

PMID:
10673047
3.

Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis.

Berleth ES, Nadadur S, Henn AD, Eppolito C, Shiojiri S, Gurtoo HL, Ehrke MJ, Mihich E.

Cancer Res. 1999 Nov 1;59(21):5497-506.

4.

Mutations induced by monofunctional and bifunctional phosphoramide mustards in supF tRNA gene.

Mudipalli A, Maccubbin AE, Nadadur SS, Struck RF, Gurtoo HL.

Mutat Res. 1997 Nov 19;381(1):49-57.

PMID:
9403030
5.

Mutations induced in a shuttle vector plasmid exposed to monofunctionally activated mitomycin C.

Maccubbin AE, Mudipalli A, Nadadur SS, Ersing N, Gurtoo HL.

Environ Mol Mutagen. 1997;29(2):143-51.

PMID:
9118966
6.

Mutations induced by dacarbazine activated with cytochrome P-450.

Mudipalli A, Nadadur SS, Maccubbin AE, Gurtoo HL.

Mutat Res. 1995 Mar;327(1-2):113-20.

PMID:
7532787
7.

Formation of 8-hydroxyguanine in DNA during mitomycin C activation.

Maccubbin AE, Ersing N, Budzinski EE, Box HC, Gurtoo HL.

Cancer Biochem Biophys. 1994 Oct;14(3):183-91.

PMID:
7728739
8.

Mutations in a shuttle vector exposed to activated mitomycin C.

Srikanth NS, Mudipalli A, Maccubbin AE, Gurtoo HL.

Mol Carcinog. 1994 May;10(1):23-9.

PMID:
8185826
9.

Altered expression of cytochrome P450 mRNA during chemical-induced hepatocarcinogenesis and following partial hepatectomy.

Habib SL, Srikanth NS, Scappaticci FA, Faletto MB, Maccubbin A, Farber E, Ghoshal AK, Gurtoo HL.

Toxicol Appl Pharmacol. 1994 Jan;124(1):139-48.

PMID:
8291055
10.

32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.

Maccubbin AE, Lee L, Struck RF, Gurtoo HL.

Chem Biol Interact. 1992 Sep 14;84(1):21-35.

PMID:
1394614
11.
12.

A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo.

Maccubbin AE, Caballes L, Riordan JM, Huang DH, Gurtoo HL.

Cancer Res. 1991 Feb 1;51(3):886-92. Erratum in: Cancer Res 1991 Jul 15;51(14):3829.

13.

Altered benzo[a]pyrene metabolism in C3H/10T1/2 cells transformed by aflatoxin B1 or 3-methylcholanthrene.

Faletto MB, Maccubbin AE, Ersing N, Kouli F, Vangalio JA, Gurtoo HL.

Toxicol Appl Pharmacol. 1990 Jun 15;104(2):351-66.

PMID:
1973007
14.

32P-postlabeling analysis of binding of the cyclophosphamide metabolite, acrolein, to DNA.

Maccubbin AE, Caballes L, Scappaticci F, Struck RF, Gurtoo HL.

Cancer Commun. 1990;2(6):207-11.

PMID:
2378783
15.

Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.

Maccubbin AE, Caballes L, Chheda GB, Struck RF, Gurtoo HL.

Biochem Biophys Res Commun. 1989 Sep 15;163(2):843-50. Erratum in: Biochem Biophys Res Commun 1990 Feb 14;166(3):1508.

PMID:
2783126
16.

Induction of aryl hydrocarbon hydroxylase and DNA adduct formation in parental and carcinogen transformed C3H/10T1/2 clone 8 cells by benzo[a]pyrene.

Faletto MB, Maccubbin AE, Koser PL, Vangalio JA, Gurtoo HL.

Cancer Biochem Biophys. 1989 May;10(3):197-205.

PMID:
2505924
17.
19.

Cytochrome P3-450 cDNA encodes aflatoxin B1-4-hydroxylase.

Faletto MB, Koser PL, Battula N, Townsend GK, Maccubbin AE, Gelboin HV, Gurtoo HL.

J Biol Chem. 1988 Sep 5;263(25):12187-9.

20.

Lipid peroxidation induced by cyclophosphamide.

Berrigan MJ, Struck RF, Gurtoo HL.

Cancer Biochem Biophys. 1987 Sep;9(3):265-70.

PMID:
3435898
21.

Aflatoxin B1-4-hydroxylase is associated with cytochrome P3-450 in C57BL/6 mouse liver.

Koser PL, Faletto MB, Bansal SK, Caballes L, Bresnick E, Hines RN, Gurtoo HL.

Biochem Biophys Res Commun. 1987 Feb 13;142(3):872-8.

PMID:
3103616
22.

Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.

Bernacki RJ, Bansal SK, Gurtoo HL.

Cancer Res. 1987 Feb 1;47(3):799-802.

23.

Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA.

Bansal SK, Love JH, Faletto MB, Gurtoo HL, Struck RF.

Cancer Biochem Biophys. 1986 Jul;8(3):193-202.

PMID:
3742481
24.

Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by beta-naphthoflavone.

Gurtoo HL, Koser PL, Bansal SK, Fox HW, Sharma SD, Mulhern AI, Pavelic ZP.

Carcinogenesis. 1985 May;6(5):675-8.

PMID:
3924427
26.

Effects of the induction of hepatic microsomal metabolism on the toxicity of cyclophosphamide.

Gurtoo HL, Bansal SK, Pavelic Z, Struck RF.

Br J Cancer. 1985 Jan;51(1):67-75.

27.
28.
29.

Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.

Marinello AJ, Bansal SK, Paul B, Koser PL, Love J, Struck RF, Gurtoo HL.

Cancer Res. 1984 Oct;44(10):4615-21.

30.

Monoclonal antibody phenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta.

Fujino T, Gottlieb K, Manchester DK, Park SS, West D, Gurtoo HL, Tarone RE, Gelboin HV.

Cancer Res. 1984 Sep;44(9):3916-23.

31.

Resolution of multiple forms of cytochrome P-450 by high-performance liquid chromatography.

Bansal SK, Love JH, Gurtoo HL.

J Chromatogr. 1984 Aug 3;297:119-27.

PMID:
6490752
32.

Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated rats.

Struck RF, Kari P, Kalin J, Montgomery JA, Marinello AJ, Love J, Bansal SK, Gurtoo HL.

Biochem Biophys Res Commun. 1984 Apr 30;120(2):390-6.

PMID:
6732764
34.

High pressure liquid chromatographic separation of multiple forms of cytochrome P-450.

Bansal SK, Love J, Gurtoo HL.

Biochem Biophys Res Commun. 1983 Nov 30;117(1):268-74.

PMID:
6661223
35.

Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.

Gurtoo HL, Marinello AJ, Berrigan MJ, Bansal SK, Paul B, Pavelic ZP, Struck RF.

Semin Oncol. 1983 Mar;10(1 Suppl 1):35-45. No abstract available.

PMID:
6836326
36.

Population distribution of placental benzo(a)pyrene metabolism in smokers.

Gurtoo HL, Williams CJ, Gottlieb K, Mulhern AI, Caballes L, Vaught JB, Marinello AJ, Bansal SK.

Int J Cancer. 1983 Jan 15;31(1):29-37.

PMID:
6299972
37.

Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.

Berrigan MJ, Marinello AJ, Pavelic Z, Williams CJ, Struck RF, Gurtoo HL.

Cancer Res. 1982 Sep;42(9):3688-95.

38.
39.

Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.

Gurtoo HL, Marinello AJ, Struck RF, Paul B, Dahms RP.

J Biol Chem. 1981 Nov 25;256(22):11691-701.

40.

Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.

Gurtoo HL, Hipkens JH, Sharma SD.

Cancer Res. 1981 Sep;41(9 Pt 1):3584-91.

41.

Role of aldehyde dehydrogenase in the metabolism-dependent biological activity of cyclophosphamide.

Hipkens JH, Struck RF, Gurtoo HL.

Cancer Res. 1981 Sep;41(9 Pt 1):3571-83. No abstract available.

42.
43.

Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes.

Paigen B, Ward E, Reilly A, Houten L, Gurtoo HL, Minowada J, Steenland K, Havens MB, Sartori P.

Cancer Res. 1981 Jul;41(7):2757-61.

44.

Inhibition of NADPH-cytochrome P450 reductase by cyclophosphamide and its metabolites.

Marinello AJ, Berrigan MJ, Struck RF, Guengerich FP, Gurtoo HL.

Biochem Biophys Res Commun. 1981 Mar 31;99(2):399-406. No abstract available.

PMID:
6786291
45.

Benzo[a]pyrene metabolism and macromolecular binding in strains of Ah responsive and Ah non-response mice.

Vaught JB, Gurtoo HL, Parker NB, Hauser LA.

Chem Biol Interact. 1980 Oct;32(1-2):151-70.

PMID:
7428109
47.

Genetic dependence of hepatic microsome-mediated depression of aflatoxin B1 activation to mutagens in Ames Salmonella typhimurium TA-98 system.

Raina V, Gurtoo HL, Berrigan M, Paigen B.

Biochem Biophys Res Commun. 1980 Jun 16;94(3):737-43. No abstract available.

PMID:
6772179
48.

Protection by N-acetylcysteine of cyclophosphamide metabolism - related in vivo depression of mixed function oxygenase activity and in vitro denaturation of cytochrome P-450.

Berrigan MJ, Gurtoo HL, Sharma SD, Struck RF, Marinello AJ.

Biochem Biophys Res Commun. 1980 Apr 14;93(3):797-803. No abstract available.

PMID:
7387676
50.

Effects of inducers and inhibitors on the metabolism of aflatoxin B1 by rat and mouse.

Gurtoo HL, Dahms RP.

Biochem Pharmacol. 1979 Dec 1;28(23):3441-9. No abstract available.

PMID:
43735

Supplemental Content

Loading ...
Support Center